1. PDMA reports high anaphylaxis rate with Kaketsuken flu vax

   News item 02 February 2013 Pages: 1 - 1

2. Opinions adopted at CHMP’s November meeting

   News item 02 February 2013 Pages: 2 - 2

3. European Commission seeks feedback on ’black symbol’

   News item 02 February 2013 Pages: 2 - 2

4. IMB publishes 2011 annual report, marking 15th anniversary

   Media release 02 February 2013 Pages: 2 - 2

5. Amgen Canada Inc. is warning of the risk of atypical femoral fracture associated with use of the osteoporosis treatment, Prolia [denosumab].

   News item 02 February 2013 Pages: 3 - 3

6. Ranbaxy Pharmaceuticals Inc., in the US, is recalling selected lots of atorvastatin 10, 20 and 40mg tablets

   News item 02 February 2013 Pages: 3 - 3

7. TGA tightens PV requirements for some drug sponsors

   News item 02 February 2013 Pages: 3 - 3

8. As of September 2012, the human papillomavirus (HPV) vaccine Gardasil replaced Cervarix in the UK’s national immunisation programme

   News item 02 February 2013 Pages: 3 - 3

9. CHMP cautions developers of PEGylated drugs for children

   News item 02 February 2013 Pages: 3 - 3

10. Fatal overdose: researchers push for better access to rescue med

    Comment 02 February 2013 Pages: 4 - 4

11. Pharmacists voice concern over introduction of generic OxyContin

    Media release 02 February 2013 Pages: 4 - 4

12. Meta-analysis shows marked variability in NSAID GI safety

    Non-clinical study 02 February 2013 Pages: 4 - 4

13. Adalimumab

    Case report 02 February 2013 Pages: 5 - 5

14. Alendronic acid/ibandronic acid

    Case report 02 February 2013 Pages: 5 - 5

15. Adalimumab/etanercept/infliximab

    Case report 02 February 2013 Pages: 5 - 5

16. Amiodarone/dabigatran etexilate interaction

    Case report 02 February 2013 Pages: 5 - 6

17. Antineoplastics

    Case report 02 February 2013 Pages: 6 - 6

18. Amitriptyline

    Case report 02 February 2013 Pages: 6 - 6

19. Antineoplastics

    Case report 02 February 2013 Pages: 6 - 6

20. Antineoplastics

    Case report 02 February 2013 Pages: 6 - 6

21. Antineoplastics

    Case report 02 February 2013 Pages: 7 - 7

22. Antineoplastics

    Case report 02 February 2013 Pages: 7 - 7

23. Antineoplastics

    Case report 02 February 2013 Pages: 7 - 7

24. Antiretrovirals

    Case report 02 February 2013 Pages: 8 - 8

25. Asparaginase

    Case report 02 February 2013 Pages: 8 - 8

26. Aripiprazole

    Case report 02 February 2013 Pages: 8 - 8

27. Aspirin/clopidogrel/ibuprofen/proton pump inhibitor interaction

    Case report 02 February 2013 Pages: 8 - 9

28. Beclometasone

    Case report 02 February 2013 Pages: 9 - 9

29. Atomoxetine/methylphenidate/venlafaxine

    Case report 02 February 2013 Pages: 9 - 9

30. Benzyl alcohol/lidocaine/triglycerides

    Case report 02 February 2013 Pages: 9 - 9

31. Bevacizumab

    Case report 02 February 2013 Pages: 9 - 10

32. Bleomycin

    Case report 02 February 2013 Pages: 10 - 10

33. Bevacizumab/ranibizumab

    Case report 02 February 2013 Pages: 10 - 10

34. Cabazitaxel

    Case report 02 February 2013 Pages: 11 - 11

35. Ciclosporin/psoralens/tacrolimus

    Case report 02 February 2013 Pages: 11 - 11

36. Botulinum toxin A

    Case report 02 February 2013 Pages: 11 - 11

37. Calcium pidolate/colecalciferol

    Case report 02 February 2013 Pages: 11 - 11

38. Citalopram/quetiapine

    Case report 02 February 2013 Pages: 12 - 12

39. Cladribine/rituximab

    Case report 02 February 2013 Pages: 12 - 12

40. Cisplatin/gimeracil/oteracil/tegafur

    Case report 02 February 2013 Pages: 12 - 12

41. Cisplatin/pemetrexed

    Case report 02 February 2013 Pages: 12 - 12

42. Clozapine

    Case report 02 February 2013 Pages: 13 - 13

43. Cytarabine

    Case report 02 February 2013 Pages: 13 - 13

44. Clopidogrel

    Case report 02 February 2013 Pages: 13 - 13

45. Dalteparin sodium

    Case report 02 February 2013 Pages: 13 - 14

46. Dexamethasone

    Case report 02 February 2013 Pages: 14 - 14

47. Dexamethasone

    Case report 02 February 2013 Pages: 14 - 14

48. Dasatinib

    Case report 02 February 2013 Pages: 14 - 14

49. Docetaxel

    Case report 02 February 2013 Pages: 15 - 15

50. Diclofenac potassium

    Case report 02 February 2013 Pages: 15 - 15